Literature DB >> 10098732

Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells.

M Urashima1, G Teoh, M Akiyama, Y Yuza, K C Anderson, K Maekawa.   

Abstract

p16INK4A (p16) tumour suppressor induces growth arrest by inhibiting function of cyclin-dependent kinase (CDK)4 and CDK6. Homozygous p16 gene deletion is frequent in primary rhabdomyosarcoma (RMS) cells as well as derived cell lines. To confirm the significance of p16 gene deletion in tumour biology of RMS, a temperature-sensitive p16 mutant (E119G) gene was retrovirally transfected into the human RMS cell line RD, which has homozygous gene deletion of p16 gene. Decrease from 40 degrees C (restrictive) to 34 degrees C (permissive) culture temperature reduced CDK6-associated kinase activity and induced G1 growth arrest. Moreover, RD-p16 cells cultured under permissive condition demonstrated differentiated morphology coupled with expressions of myogenin and myosin light chain. These suggest that deletion of p16 gene may not only facilitate growth but also inhibit the myogenic differentiation of RD RMS cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098732      PMCID: PMC2362237          DOI: 10.1038/sj.bjc.6690165

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

2.  Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).

Authors:  C De Giovanni; P Nanni; G Nicoletti; C Ceccarelli; K Scotlandi; L Landuzzi; P L Lollini
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

3.  Consistent chromosomal translocation in alveolar rhabdomyosarcoma.

Authors:  C Turc-Carel; S Lizard-Nacol; E Justrabo; M Favrot; T Philip; E Tabone
Journal:  Cancer Genet Cytogenet       Date:  1986-01-15

4.  Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells.

Authors:  J W Schneider; W Gu; L Zhu; V Mahdavi; B Nadal-Ginard
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.

Authors:  O M El-Badry; C Minniti; E C Kohn; P J Houghton; W H Daughaday; L J Helman
Journal:  Cell Growth Differ       Date:  1990-07

6.  Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.

Authors:  D N Shapiro; J E Sublett; B Li; J R Downing; C W Naeve
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

8.  Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.

Authors:  W Gu; J W Schneider; G Condorelli; S Kaushal; V Mahdavi; B Nadal-Ginard
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

9.  Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias.

Authors:  S Ogawa; N Hirano; N Sato; T Takahashi; A Hangaishi; K Tanaka; M Kurokawa; T Tanaka; K Mitani; Y Yazaki
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

10.  Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia.

Authors:  M Urashima; G Teoh; A Ogata; D Chauhan; S P Treon; Y Sugimoto; C Kaihara; M Matsuzaki; Y Hoshi; J A DeCaprio; K C Anderson
Journal:  Clin Cancer Res       Date:  1997-11       Impact factor: 12.531

View more
  6 in total

1.  Genetic and epigenetic changes in human epithelial cells immortalized by telomerase.

Authors:  D G Farwell; K A Shera; J I Koop; G A Bonnet; C P Matthews; G W Reuther; M D Coltrera; J K McDougall; A J Klingelhutz
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Effects of p16 gene on biological behaviours in hepatocellular carcinoma cells.

Authors:  Jian-Zhao Huang; Sui-Sheng Xia; Qi-Fa Ye; Han-Ying Jiang; Zhong-Hua Chen
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

3.  Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization.

Authors:  C-Y Kan; V W Wen; E Pasquier; K Jankowski; M Chang; L A Richards; M Kavallaris; K L MacKenzie
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

4.  Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes.

Authors:  E Dellambra; O Golisano; S Bondanza; E Siviero; P Lacal; M Molinari; S D'Atri; M De Luca
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

Review 5.  Oral rhabdomyosarcoma: A review.

Authors:  Ankita Tandon; Kanika Sethi; Anand Pratap Singh
Journal:  J Clin Exp Dent       Date:  2012-12-01

6.  Response to Electrostimulation Is Impaired in Muscle Cells from Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Matthias Catteau; Emilie Passerieux; Léo Blervaque; Farés Gouzi; Bronia Ayoub; Maurice Hayot; Pascal Pomiès
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.